Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
907 GBX | +1.68% | +6.08% | +11.22% |
May. 07 | AstraZeneca target raised; Antofagasta lowered | AN |
Apr. 22 | JTC sights acquisition to expand US trust administration services | AN |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- The group's high margin levels account for strong profits.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- Analysts have consistently raised their revenue expectations for the company, which provides good prospects for the current and next years in terms of revenue growth.
- For the past twelve months, EPS forecast has been revised upwards.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The firm trades with high earnings multiples: 26.33 times its 2024 earnings per share.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company is not the most generous with respect to shareholders' compensation.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Investment Management & Fund Operators
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+11.22% | 1.81B | C | ||
-4.12% | 116B | A- | ||
+0.88% | 94.79B | C+ | ||
+13.72% | 66.36B | - | B+ | |
+17.46% | 64.4B | C | ||
+10.49% | 42.92B | C+ | ||
+12.14% | 42.2B | A- | ||
+22.84% | 35.68B | A- | ||
+3.53% | 24.84B | B | ||
-2.76% | 22.7B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- JTC Stock
- Ratings JTC PLC